Clinical trial
Postprandial Glycaemic Changes When Patients With Type 2 Diabetes Consume the New KDD Products
NCT06135935 is registered in ClinicalTrials.gov with Dasman Diabetes Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postprandial Glycaemic Changes When Patients With Type 2 Diabetes Consume the New KDD Products
- Lead sponsor
- Dasman Diabetes Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 12, 2023
- Completion date
- January 30, 2024
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes